Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
18.23
-1.22 (-6.27%)
Jun 17, 2025, 4:00 PM - Market closed
Beta Bionics Market Cap
Beta Bionics has a market cap or net worth of $790.39 million as of June 18, 2025.
Market Cap
790.39M
Enterprise Value
565.89M
1-Year Change
n/a
Ranking
Category
Stock Price
18.23
Market Cap Chart
Since the IPO on January 30, 2025, Beta Bionics's market cap has increased from $695.12M to $790.39M, an increase of 13.70%. That is a compound annual growth rate of 40.80%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 16, 2025 | 843.28M | 1.89% |
Jun 13, 2025 | 827.67M | -2.05% |
Jun 12, 2025 | 845.01M | 1.99% |
Jun 11, 2025 | 828.54M | -0.83% |
Jun 10, 2025 | 835.48M | -0.72% |
Jun 9, 2025 | 841.55M | 1.73% |
Jun 6, 2025 | 827.24M | -2.40% |
Jun 5, 2025 | 847.62M | 0.51% |
Jun 4, 2025 | 843.28M | 8.30% |
Jun 3, 2025 | 778.68M | -3.91% |
Jun 2, 2025 | 810.33M | 8.41% |
May 30, 2025 | 747.46M | 12.24% |
May 29, 2025 | 665.95M | 6.44% |
May 28, 2025 | 625.63M | -3.48% |
May 27, 2025 | 648.18M | 3.60% |
May 23, 2025 | 625.63M | -6.96% |
May 22, 2025 | 672.46M | -0.32% |
May 21, 2025 | 674.62M | -1.77% |
May 20, 2025 | 686.76M | 4.90% |
May 19, 2025 | 654.68M | 5.15% |
May 16, 2025 | 622.60M | 4.28% |
May 15, 2025 | 597.02M | 7.24% |
May 14, 2025 | 556.69M | -2.73% |
May 13, 2025 | 572.30M | -6.91% |
May 12, 2025 | 614.79M | 1.65% |
May 9, 2025 | 604.82M | -6.44% |
May 8, 2025 | 646.44M | 3.76% |
May 7, 2025 | 623.03M | 26.61% |
May 6, 2025 | 492.09M | -2.81% |
May 5, 2025 | 506.31M | -1.27% |
May 2, 2025 | 512.82M | 6.19% |
May 1, 2025 | 482.91M | 0.81% |
Apr 30, 2025 | 479.00M | 0.55% |
Apr 29, 2025 | 476.40M | 1.76% |
Apr 28, 2025 | 468.17M | -1.46% |
Apr 25, 2025 | 475.10M | -0.90% |
Apr 24, 2025 | 479.44M | 5.74% |
Apr 23, 2025 | 453.43M | 0.67% |
Apr 22, 2025 | 450.39M | 3.38% |
Apr 21, 2025 | 435.66M | -9.78% |
Apr 17, 2025 | 482.91M | 1.83% |
Apr 16, 2025 | 474.24M | 4.39% |
Apr 15, 2025 | 454.30M | 0.19% |
Apr 14, 2025 | 453.43M | -4.12% |
Apr 11, 2025 | 472.94M | 2.06% |
Apr 10, 2025 | 463.40M | -9.48% |
Apr 9, 2025 | 511.95M | 21.63% |
Apr 8, 2025 | 420.92M | -6.99% |
Apr 7, 2025 | 452.56M | 5.35% |
Apr 4, 2025 | 429.59M | -7.99% |
Apr 3, 2025 | 466.87M | -10.62% |
Apr 2, 2025 | 522.35M | 7.21% |
Apr 1, 2025 | 487.24M | -8.17% |
Mar 31, 2025 | 530.59M | 4.53% |
Mar 28, 2025 | 507.61M | -7.58% |
Mar 27, 2025 | 549.23M | -3.65% |
Mar 26, 2025 | 570.04M | -13.60% |
Mar 25, 2025 | 659.77M | 3.66% |
Mar 24, 2025 | 636.46M | -1.66% |
Mar 21, 2025 | 647.18M | -3.76% |
Mar 20, 2025 | 672.46M | -0.63% |
Mar 19, 2025 | 676.75M | -0.22% |
Mar 18, 2025 | 678.25M | -4.73% |
Mar 17, 2025 | 711.89M | 13.22% |
Mar 14, 2025 | 628.75M | 4.49% |
Mar 13, 2025 | 601.75M | -3.17% |
Mar 12, 2025 | 621.46M | -3.46% |
Mar 11, 2025 | 643.75M | 0.20% |
Mar 10, 2025 | 642.46M | -7.13% |
Mar 7, 2025 | 691.75M | -9.38% |
Mar 6, 2025 | 763.32M | -1.44% |
Mar 5, 2025 | 774.47M | -2.17% |
Mar 4, 2025 | 791.61M | -11.96% |
Mar 3, 2025 | 899.19M | 0.05% |
Feb 28, 2025 | 898.76M | 5.32% |
Feb 27, 2025 | 853.33M | -0.40% |
Feb 26, 2025 | 856.76M | 4.28% |
Feb 25, 2025 | 821.61M | -6.94% |
Feb 24, 2025 | 882.90M | 0.15% |
Feb 21, 2025 | 881.62M | -1.44% |
Feb 20, 2025 | 894.47M | -4.31% |
Feb 19, 2025 | 934.76M | -0.68% |
Feb 18, 2025 | 941.19M | 0.69% |
Feb 14, 2025 | 934.76M | 0.28% |
Feb 13, 2025 | 932.19M | -1.09% |
Feb 12, 2025 | 942.48M | -2.53% |
Feb 11, 2025 | 966.91M | 0.13% |
Feb 10, 2025 | 965.62M | -4.13% |
Feb 7, 2025 | 1.01B | 0.13% |
Feb 6, 2025 | 1.01B | 2.76% |
Feb 5, 2025 | 978.91M | -0.70% |
Feb 4, 2025 | 985.76M | 1.10% |
Feb 3, 2025 | 975.05M | -4.45% |
Jan 31, 2025 | 1.02B | 46.81% |
Jan 30, 2025 | 695.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 735.67B |
Johnson & Johnson | 372.72B |
Novo Nordisk | 355.28B |
AbbVie | 336.50B |
UnitedHealth Group | 277.58B |
Abbott Laboratories | 234.55B |
Novartis AG | 234.52B |
AstraZeneca | 231.58B |